1.
An. bras. dermatol
; 97(1): 102-104, Jan.-Feb. 2022. graf
Article
in English
| LILACS
| ID: biblio-1360097
Subject(s)
Humans , Female , Pregnancy , Pregnancy Complications/diagnosis , Exanthema , Folliculitis/diagnosis , Pregnancy Trimesters , Pruritus/diagnosis , Pregnant Women
2.
An Bras Dermatol
; 97(1): 102-104, 2022.
Article
in English
| MEDLINE
| ID: mdl-34794830
3.
Hansen. int
; 35(1): 53-56, 2010.
Article
in Portuguese
| LILACS, Sec. Est. Saúde SP, SESSP-ILSLPROD, Sec. Est. Saúde SP, SESSP-ILSLACERVO, Sec. Est. Saúde SP
| ID: lil-789330
ABSTRACT
Após re-introdução no mercado, a Talidomida tornou-se a droga mais eficaz no tratamento do eritema nodoso hânsenico, além de opção terapêutica para diversas doenças, como mieloma múltiplo. Contudo, o crescente uso desta, associado a corticóides sistêmicos e quimioterápicos, resultou em aumento de efeitos adversos pouco reconhecidos, como trombose venosa profunda.
After being reintroduced in the market, thalidomide has become the most effective drug in the treatment of erythema nodosum leprosum and a therapeutic option for several diseases, such as multiple myeloma. However, its increasing use, combined with systemic steroids and chemotherapy has also increased little recognized adverse effects, such as deep vein thrombosis.